SNSS Sunesis Pharmaceuticals Inc

SOUTH SAN FRANCISCO, Calif., Feb. 4 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced that the company will be presenting at the upcoming 11th Annual BIO CEO & Investor Conference at 11:30 a.m. Eastern Time on February 10, 2009 at the Waldorf-Astoria Hotel in New York City, NY. The live webcast of this presentation will be available on the Sunesis website at http://ir.sunesis.com/. A replay of the webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks. About Sunesis Pharmaceuticals Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing voreloxin in multiple indications to improve the lives of people with cancer. For additional information on Sunesis Pharmaceuticals, please visit http://www.sunesis.com/. SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc. DATASOURCE: Sunesis Pharmaceuticals, Inc. CONTACT: Eric Bjerkholt of Sunesis Pharmaceuticals, Inc., +1-650-266-3717 Web site: http://www.sunesis.com/

Copyright